Plain-English translation of NCT06645678 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This study is testing whether and , combined with a steroid medication, can help people whose multiple myeloma has come back or stopped responding to previous treatments. The trial has two parts: first, a small group will help doctors figure out the safest dose, and then a larger group will test how well the medication combination works over two years.
Multiple myeloma often becomes resistant to current treatments, leaving patients with fewer options. This trial is exploring whether this new medication combination might help people who have already tried other standard therapies.
You likely qualify if…
You likely don't qualify if…
You will take the medications by mouth and receive injections as part of 28-day treatment cycles. You'll attend regular clinic visits for blood tests, physical exams, and imaging scans to see how well the treatment is working. The study lasts at least two years, with more frequent visits at the start and then periodic check-ins throughout.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Singapore
South Korea